Acceder

Publicaciones - Farmacología Celular y Molecular

Cargando...
Luque Del Moral R, Gastelurrutia MA, Martinez-Martinez F, Jacome JA, Dago A, Suarez B, Fikri-Benbrahim N, Marti M, Nunez C, Sierra-Alarcon S, Fernandez-Gomez FJ. Effect of Pharmaceutical Intervention in Pharmacologically Treated Hypertensive Patients-A Cluster-Randomized Clinical Trial: AFPRES-CLM Study. J Pers Med. 2023 Oct 11;13(10):1484. doi: 10.3390/jpm13101484. PubMed PMID: 37888095; PubMed Central PMCID: PMC10608270.
AÑO: 2023; IF: 3.0
37888095
Montesinos J, Montagud-Romero S, Nunez C. Editorial: Unraveling vulnerability factors in addiction drug use and potential treatments. Front Neurosci. 2022 Jul 29;16:958492. doi: 10.3389/fnins.2022.958492. eCollection 2022. No abstract available. PubMed PMID: 35971562; PubMed Central PMCID: PMC9374589.
AÑO: 2022; IF: 5.152
35971562
Paiva I, Cellai L, Meriaux C, Poncelet L, Nebie O, Saliou JM, Lacoste AS, Papegaey A, Drobecq H, Le Gras S, Schneider M, Malik EM, Muller CE, Faivre E, Carvalho K, Gomez-Murcia V, Vieau D, Thiroux B, Eddarkaoui S, Lebouvier T, Schueller E, Tzeplaeff L, Grgurina I, Seguin J, Stauber J, Lopes LV, Buee L, Buee-Scherrer V, Cunha RA, Ait-Belkacem R, Sergeant N, Annicotte JS, Boutillier AL, Blum D. Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription. J Clin Invest. 2022 Jun 15;132(12):e149371. doi: 10.1172/JCI149371. PubMed PMID: 35536645; PubMed Central PMCID: PMC9197525.
AÑO: 2022; IF: 15.9
35536645
Benderradji H, Kraiem S, Courty E, Eddarkaoui S, Bourouh C, Faivre E, Rolland L, Caron E, Besegher M, Oger F, Boschetti T, Carvalho K, Thiroux B, Gauvrit T, Nicolas E, Gomez-Murcia V, Bogdanova A, Bongiovanni A, Muhr-Tailleux A, Lancel S, Bantubungi K, Sergeant N, Annicotte JS, Buee L, Vieau D, Blum D, Buee-Scherrer V. Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model. Front Mol Neurosci. 2022 Feb 16;15:841892. doi: 10.3389/fnmol.2022.841892. eCollection 2022. PubMed PMID: 35250480; PubMed Central PMCID: PMC8889017.
AÑO: 2022; IF: 4.8
35250480
Dewaeles E, Carvalho K, Fellah S, Sim J, Boukrout N, Caillierez R, Ramakrishnan H, Van der Hauwaert C, Vijaya Shankara J, Martin N, Massri N, Launay A, Folger JK, de Schutter C, Larrue R, Loison I, Goujon M, Jung M, Le Gras S, Gomez-Murcia V, Faivre E, Lemaire J, Garat A, Beauval N, Maboudou P, Gnemmi V, Gibier JB, Buee L, Abbadie C, Glowacki F, Pottier N, Perrais M, Cunha RA, Annicotte JS, Laumet G, Blum D, Cauffiez C. Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects. J Clin Invest. 2022 Nov 15;132(22):e152924. doi: 10.1172/JCI152924. PubMed PMID: 36377661; PubMed Central PMCID: PMC9663157.
AÑO: 2022; IF: 15.9
36377661
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

Farmacología Celular y Molecular